EP Patent

EP1463509A1 — Type 4 phosphodiesterase inhibitors and uses thereof

Assigned to Merck Patent GmbH · Expires 2004-10-06 · 22y expired

What this patent protects

The invention relates to the use of type 4 phosphodiesterase inhibitors (PDE IV inhibitors) to treat diseases and to combinations of PDE IV inhibitors with other drugs.

USPTO Abstract

The invention relates to the use of type 4 phosphodiesterase inhibitors (PDE IV inhibitors) to treat diseases and to combinations of PDE IV inhibitors with other drugs.

Drugs covered by this patent

Patent Metadata

Patent number
EP1463509A1
Jurisdiction
EP
Classification
—
Expires
2004-10-06
Drug substance claim
No
Drug product claim
No
Assignee
Merck Patent GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.